Search - tctmd.com

Displaying 21 - 40 of 283

Sort: Relevancy | Date

Presentation THT 2026

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Presenter: Matthew Ramm

March 02, 2026

Presentation THT 2026

Smart Adaptive LVAD to Tailor its Operation to Physiological State during Day

Presenter: Jonathan Grinstein

March 02, 2026

Presentation THT 2026

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Presenter: Thomas Cascino

March 02, 2026

Presentation THT Abstracts 2026

Running Out of Options: When LVAD Complications Limit MCS Strategies

Presenter: Madison Rose-Malkamäki

March 02, 2026

Presentation THT 2026

Increased Psoas Muscle Recovery After LVAD Implantation Is Associated with Decreased Major Bleed Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 02, 2026

News Conference News THT 2026

THT 2026: What to Expect in Boston

Todd Neale

February 23, 2026

Presentation TCT 2025

A Versatile Implantable Micro-Pressure Sensor: FIH Study in LVAD Patients (Microtech)

Presenter: Nir Uriel

October 28, 2025

Presentation TCT 2025

TCT 1779: Hybrid Approach, High Risk MVD PCI With LVAD Support, IVL, IVUS: Surgical Access From the Axillary Artery in a Patient Without the Possibility of Percutaneous Puncture

Presenter: Roman Wojdyla

October 25, 2025

Presentation TCT 2025

TCT 1621: Coronary Sinus Reducer Implantation for Refractory Angina in an LVAD-Supported Patient With Ischemic Cardiomyopathy

Presenter: Aimane Mechroubi

October 25, 2025

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

L.A. McKeown

October 14, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

Presentation NY Valves 2025

Valve Gone Rogue: Salvaging TAVR Failure in an LVAD-Supported Heart

Presenter: Mohamed Zghouzi

June 27, 2025

Presentation NY Valves 2025

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Presenter: Nir Uriel

June 25, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

Presentation THT 2025

Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes: An Analysis of the Society Of Thoracic Surgeons National Intermacs Database

Presenter: Manreet Kanwar

February 13, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Advertisement

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Smart Adaptive LVAD to Tailor its Operation to Physiological State during Day

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Running Out of Options: When LVAD Complications Limit MCS Strategies

Increased Psoas Muscle Recovery After LVAD Implantation Is Associated with Decreased Major Bleed Readmission in Cardiogenic Shock Patients

THT 2026: What to Expect in Boston

A Versatile Implantable Micro-Pressure Sensor: FIH Study in LVAD Patients (Microtech)

TCT 1779: Hybrid Approach, High Risk MVD PCI With LVAD Support, IVL, IVUS: Surgical Access From the Axillary Artery in a Patient Without the Possibility of Percutaneous Puncture

TCT 1621: Coronary Sinus Reducer Implantation for Refractory Angina in an LVAD-Supported Patient With Ischemic Cardiomyopathy

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Valve Gone Rogue: Salvaging TAVR Failure in an LVAD-Supported Heart

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes: An Analysis of the Society Of Thoracic Surgeons National Intermacs Database

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content